|
1) Hashimoto A, Nishikawa T, Hayashi T, et al. The presence of free D-serine in rat brain. FEBS Lett. 1992; 296: 33-6
|
|
|
|
2) Wolosker H, Sheth KN, Takahashi M, et al. Purification of serine racemase: biosynthesis of the neuromodulator D-serine. Proc Natl Acad Sci U S A. 1999; 96: 721-5
|
|
|
|
|
|
3) Basu AC, Tsai GE, Ma CL, et al. Targeted disrup-tion of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry. 2009; 14: 719-27
|
|
|
|
|
|
4) De Miranda J, Panizzutti R, Foltyn VN, et al. Cofactors of serine racemase that physiologically stimulate the synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine. Proc Natl Acad Sci U S A. 2002; 99: 14542-7
|
|
|
|
|
|
5) Foltyn VN, Bendikov I, De Miranda J, et al. Serine racemase modulates intracellular D-serine levels through an alpha, beta-elimination activity. J Biol Chem. 2005; 280: 1754-63
|
|
|
|
|
|
6) Morikawa A, Hamase K, Inoue T, et al. Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino acid oxidase activity. J Chromatogr B Biomed Sci Appl. 2001; 757: 119-25
|
|
|
|
|
|
7) Miya K, Inoue R, Takata Y, et al. Serine racemase is predominantly localized in neurons in mouse brain. J Comp Neurol. 2008; 510: 641-54
|
|
|
|
|
|
8) Panatier A, Theodosis DT, Mothet JP, et al. Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell. 2006; 125: 775-84
|
|
|
|
|
|
9) Henneberger C, Papouin T, Oliet SH, et al. Long-term potentiation depends on release of D-serine from astrocytes. Nature. 2010; 463: 232-6
|
|
|
|
|
|
10) Wolosker H. Serine racemase and the serine shuttle between neurons and astrocytes. Biochim Biophys Acta. 2011; in press
|
|
|
|
|
|
11) Dumin E, Bendikov I, Foltyn VN, et al. Modu-lation of D-serine levels via ubiquitin-dependent proteasomal degradation of serine racemase. J Biol Chem. 2006; 281: 20291-302
|
|
|
|
|
|
12) Martineau M, Galli T, Baux G, et al. Confocal imaging and tracking of the exocytotic routes for D-serine-mediated gliotransmission. Glia. 2008; 56: 1271-84
|
|
|
|
|
|
13) Schell MJ, Molliver ME, Snyder SH. D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci U S A. 1995; 92: 3948-52
|
|
|
|
|
|
14) Mothet JP, Parent AT, Wolosker H, et al. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 2000; 97: 4926-31
|
|
|
|
|
|
15) Shleper M, Kartvelishvily E, Wolosker H. D-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices. J Neurosci. 2005; 25: 9413-7
|
|
|
|
|
|
16) Chatterton JE, Awobuluyi M, Premkumar LS, et al. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature. 2002; 415: 793-8
|
|
|
|
|
|
17) Cavara NA, Hollmann M. Shuffling the deck anew: how NR3 tweaks NMDA receptor function. Mol Neurobiol. 2008; 38: 16-26
|
|
|
|
|
|
18) Kakegawa W, Miyoshi Y, Hamase K, et al. D-serine regulates cerebellar LTD and motor coordination through the delta2 glutamate re-ceptor. Nat Neurosci. 2011; 14: 603-11
|
|
|
|
|
|
19) Labrie V, Roder JC. The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia. Neurosci Biobehav Rev. 2010; 34: 351-72
|
|
|
|
|
|
20) Inoue R, Hashimoto K, Harai T, et al. NMDA- and beta-amyloid1-42-induced neurotoxicity is attenuated in serine racemase knock-out mice. J Neurosci. 2008; 28: 14486-91
|
|
|
|
|
|
21) Mustafa AK, Ahmad AS, Zeynalov E, et al. Serine racemase deletion protects against cerebral ischemia and excitotoxicity. J Neurosci. 2010; 30: 1413-6
|
|
|
|
|
|
22) Wu SZ, Bodles AM, Porter MM, et al. Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide. J Neuroinflammation. 2004; 1: 2
|
|
|
|
|
|
23) Sasabe J, Chiba T, Yamada M, et al. D-serine is a key determinant of glutamate toxicity in amyo-trophic lateral sclerosis. EMBO J. 2007; 26: 4149-59
|
|
|
|
|
|
24) Mitchell J, Paul P, Chen HJ, et al. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proc Natl Acad Sci U S A. 2010; 107: 7556-61
|
|
|
|
|